Healthcare Realty Trust Incorporated
Here’s whether Healthcare Realty Trust Incorporated (HR) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: trading above the 200-day MA (long-term uptrend intact); strong 1-year return of +18.0%. Concerns: below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.26% over 10 days); RSI 16 — oversold; 3-month momentum negative (-5.1%). Currently 12.7% off its 52-week high. Score: -1/7.
HR is holding above its long-term 200-day MA ($18.63) but has slipped below the 50-day MA ($20.50), pointing to short-term weakness in an otherwise intact trend. An RSI of 16.5 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +18.0% compares to +20.4% for SPY (trailed the market by 2.3%).